Chemicals
11 Apr 2025
New CLP Hazard Classes & Implications for REACH Dossier Updates

In 2023, Delegated Regulation 2023/707 was published, amending CLP Regulation (EC) No 1272/2008, setting out new hazard classes and criteria for the...

The recent proposal to revise the REACH regulations has stirred significant reactions across the European chemicals industry.Presented during the 54...
26 Mar 2025
15 Years of Read-Across Under EU REACH: Lessons from ECHA’s Testing Proposal & Compliance Check Decisions

At the recent Society of Toxicology (SOT) conference, Dr. Ivan Rusyn of Texas A&M University, presented a compelling analysis titled “To Accept ...
26 Mar 2025
Safe & Sustainable by Design – Critical Tool for Early Hazard & Risk Identification

At the recent Society of Toxicology (SOT) 2025 Annual Meeting, the EU’s ‘Safe and Sustainable by Design’ (SSbD) framework emerged as a prominent top...

On the 10th March 2025 the new Statutory Instrument (S.I.) regarding REACH Fees and Charges, amending (EC) No 340/2008 under UK REACH, was laid befo...
07 Mar 2025
ECHA Dose Setting Advice for DART: Walking the Tightrope of Welfare Limits and Advice Interpretation Leads to Variance in Outcome Between Labs

Poster PresentationSOT 64th Annual Meeting and ToxExpoOrlando - March 16-20 2025Abstract:The introduction of ECHA’s dose level setting advice for re...
07 Mar 2025
CCPD: A Potential Safer Alternative to 6PPD for Human Health

Poster PresentationSOT 64th Annual Meeting and ToxExpoOrlando - March 16-20 2025Abstract:Due to well publicised human health and environmental conce...
07 Mar 2025
CCPD: A Potential Safer Alternative to 6PPD for the Environment

Poster PresentationSOT 64th Annual Meeting and ToxExpoOrlando - March 16-20 2025Abstract:Due to well publicised environmental and human health conce...

Pressure is increasing for PFAS manufacturers and users to minimise PFAS emissions and find PFAS alternatives – particularly due to the potential to...

12 questions PFAS manufacturers, importers and users should consider for continued market access, product viability and regulatory compliance in the...